Corporate Member


Accelerate Diagnostics

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system automates the steps to report phenotypic antibiotic susceptibility results in about 7 hours direct from positive blood cultures, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient 1–2 days faster than existing methods.